Prostate Cancer Research Paper

Page Description: Prostate cancer can be metastatic if early treatment is not performed. Effective treatment methods like radiation therapy can be helpful in treating the associated symptoms.

Another method to detect this cancer is with a Prostate Specific Antigen (PSA). Protein in the blood that is produced only by prostate cells is reflected the volume of both benign and malignant prostate tissue in the PSA. The higher the PSA level is the more likely it is that Prostate Cancer present. (“Prostate

Benign prostatic hyperplasia (BPH) or an enlarged prostate is a common urological condition in ageing males. At least 50% of men over age 50 have some degree of prostatic enlargement. This can cause complications such as Frequent urination, UTI’s, blood in the urine, trouble urinating, and a slow flow in the urination. When the, When the Benign Prostatic Hyperplasia occurs in the second stage of growth, the prostate becomes enlarged and begins to push down on the urethra, which causes a blockage and restricts the flow of the urine and when this occurs a transurethral resection of the prostrate is the treatment of choice. “According to” TURP is the second most common surgical procedure in men over 65 years.

At the Prostate Cancer Symposium, sponsored by the American Society of Clinical Oncology (ASCO), two leading clinicians and cancer researchers engaged in a point / counterpoint discussion that proved to be illuminating and directional in moving the focus. Though the discussion was themed to create positions of pro versus con, the reality of their arguments really showed more agreement than not.

Practicing evidence-based medicine is imperative in today’s healthcare upbringing for the reason that this sculpts of care offers clinicians a line of attack to accomplish objectives of enhanced eminence, better patient contentment, and reduced expenditure. To understand how, this works, consider the prostate cancer example. With evidence-based medicine, a contributor can gauge the potency of the confirmation as well as the risks and reimbursement of ordering indicative tests and treatments for each cancer patient. Such an approach, united with the provider’s clinical understanding makes the provider to healthier envisage if a treatment will do more harm than good. It establishes a systematic move towards to considerate for patients with specific

The best treatment for the prevention of cancer is early detection. In September, The National Football League (NFL) teamed up with Cancer Treatment Centers of America and LabCorp to educate men about the risks of prostate cancer and to offer Prostate Specific Antigen (PSA) screening.

Benign prostatic hyperplasia is the health topic I chose to do research over. This disease is commonly found in the aging male and typically begins when they are 40 years old. This disease can start during the males 40s but “he may not experience symptoms until much later depending on individual condition progress” (Callahan 284). This disease can be complex and the pathophysiology is long.

The first reason being the level accuracy of PSA testing is questionable. The test determines a positive for the cancer based on the levels of prostate-specific antigens in the blood of the patient, which can be abnormally high for multiple other reasons not related to prostate cancer. The major evidence supporting said claim is that individuals with more than 4.0 ng per mL (the threshold to test positive) can have false positive rates of 70% (Mulhem 2). The second reason would be the implications of testing positive for prostate cancer, including but not limited to unnecessary treatment of the disease. While the analysis does not back up unnecessary treatment with any statistical evidence, it does go to explain further tests and procedures to confirm and understand the nature of the patient’s condition. This bleeds over to the negative physical and psychological side-effects of regular prostate cancer screening cited by the analysis. Mulhem explains that after testing positive for prostate cancer, more tests are performed to determine the accuracy of the screening and if so, reveal the specificities of the cancer. The most common of these tests being the prostate biopsy, a procedure that causes a significant portion of participants to develop moderate to severe problems requiring a follow-up with their doctor (Mulhem

Today, prostate cancer is usually detected through screening, and there are two methods for early detection. The prostate-specific antigen test (PSA) is used, but there are

In the case for PSA screening, PCa is the leading internal malignancy in US men and the second leading cause of cancer death in American men. Early detection of prostate cancers offers the best chance of cure. The PSA blood test is the best chance of cure. Currently, the PSA blood test is the best currently available way to detect PCa and it is easy, safe and inexpensive. PSA test results is a piece of information, it is what doctors do with the information that becomes the issue. However, the great majority of PSA detected tumors have the histologic characteristics of clinically important cancers. Also, PSA detection has found tumors early advancing the diagnosis by Seeral years (5-13) and prostate cancer mortality rates in U.S have decreased by 4% (patho book) since 1992, which is 5 years after initiation of prostate screenings. The dilemma is over treating the clinically unimportant disease versus under

Prostate cancer is the second most frequently diagnosed cancer and the sixth leading cause of cancer death in males. Incidence rates vary more than 25-fold worldwide, with the highest rates in the developed countries this may be due to the widespread use of prostate-specific antigen testing and subsequent prostate biopsy in these regions [1]. Overall, the complex morphology, histologic heterogeneity, and the early signs of high malignant potential preclude a straightforward assessment of the metastatic potential of localized prostate carcinoma and show the requirement for extra clinical and pathologic tests for the evaluation of prostate carcinoma stage and clinical behavior[2]

Prostate cancer is abnormal cells that grow within the prostate gland and can spread to other body systems. Prostate cancer begins when cells in the prostate gland start to grow uncontrollably. The prostate is a gland found only in males. It makes some of the fluid that is part of semen. Prostate cancer is the second leading cause of cancer death in men in the United States and the fourth leading cause of death in black men overall. Studies show that black males are more than twice likely to die of prostate cancer than other counterparts.

Many patients are dying of prostate cancer as standard treatments are not providing the necessary results. There are new types of immunotherapy drugs which are known to work miracles for several forms of cancer. The probability of this drug helping those with prostate cancer is extremely small. There has yet to be evidence collected about the benefits and pitfalls of the treatment. If doctors were to test it on patients outside of a clinical trial, then that could be up for debate within the medical community. The drugs can have potentially deadly side effects including liver failure and nerve damage, but most patients only experience minor problems. Doctors are able to determine from biomarkers if immunotherapy treatment will help patients, but that testing is not completely accurate. Some doctors believe that they should try every possible

Cancer. One word, a million different emotions. Cancer is a term used to describe a group of diseases in which abnormal cells divide and invade other tissues at an uncontrollable rate. Cancer cells rapidly travel through blood and lymph systems to other parts of the body. With over 100 different types of cancers this year alone over 500,000 Americans are expected to die from cancer, making it the second leading cause of death in the US. (TLCF,2014- Thomas Latimer Cancer Foundation) Among the vast forms of cancer, prostate cancer is the second most common cancer in American men after skin cancer. Prostate cancer affects males as it is found in the prostate gland an organ found in the male reproductive system. Prostate cancer has many faucets

Research has indicated that prostate cancer is more likely to be observed rather than treated directly. These observations come from the University of California, San Francisco, where the concerns of overtreatment are being addressed.